Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Brain Tumor Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10014-012-0127-8PMID 23250387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.

  2012cited by this paper
• Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact.

  2012cited by this paper
• Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

  2012cited by this paper
• Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.

  2012cited by this paper
• Atypical and anaplastic meningiomas treated with bevacizumab

  2012cited by this paper
• Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms.

  2011cited by this paper
• EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features

  2011cited by this paper
• Conservative management of ossification of the posterior longitudinal ligament. A review.

  2011cited by this paper
• Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

  2011cited by this paper
• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

  2011cited by this paper
• Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma

  2010cited by this paper
• Eicosanoids and cancer

  2010cited by this paper
• Aspirin use and survival after diagnosis of colorectal cancer.

  2009cited by this paper
• Advances in meningioma therapy

  2009cited by this paper
• Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

  2009cited by this paper
• Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

  2009cited by this paper
• LONG‐TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION

  2009cited by this paper
• Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer

  2008cited by this paper
• Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma.

  2007cited by this paper
• Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

  2007cited by this paper
• WHO classification of tumours of the central nervous system

  2007influential reference
• Cyclooxygenase-2 (COX-2) Overexpression in Meningiomas: Real Time PCR and Immunohistochemistry

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Regulation of cyclooxygenase-2 expression by cyclic AMP.

  2007cited by this paper
• Celecoxib inhibits meningioma tumor growth in a mouse xenograft model

  2007cited by this paper
• Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.

  2007cited by this paper
• Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas?

  2007cited by this paper
• Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer

  2006cited by this paper
• Differential involvement of ERK1‐2 and p38MAPK activation on Swiss 3T3 cell proliferation induced by prostaglandin F2α

  2006cited by this paper
• Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.

  2005cited by this paper
• High throughput screening of meningioma biomarkers using a tissue microarray

  2005cited by this paper
• Cyclooxygenase-2 and its role in colorectal cancer development

  2004cited by this paper
• Meningioma Pathology, Genetics, and Biology

  2004cited by this paper
• COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

  2004cited by this paper
• Cyclic AMP Promotes cAMP-responsive Element-binding Protein-dependent Induction of Cellular Inhibitor of Apoptosis Protein-2 and Suppresses Apoptosis of Colon Cancer Cells through ERK1/2 and p38 MAPK*

  2004cited by this paper
• Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.

  2004cited by this paper
• Cyclooxygenase-2 (COX-2) Expression in Human Meningioma as a Function of Tumor Grade

  2003cited by this paper
• Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.

  2003cited by this paper
• The eicosanoid cascade: possible role in gliomas and meningiomas

  2003cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas.

  2003cited by this paper
• Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2

  2003cited by this paper
• COX-2: a target for colon cancer prevention.

  2002cited by this paper
• Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

  2002cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas.

  2001cited by this paper
• Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients.

  2000cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages.

  1998cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Inducible cyclooxygenase and nitric oxide synthase.

  1995cited by this paper
• Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

  1995cited by this paper
• Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

  1995cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

  1993cited by this paper

• Meningioma growth beneath the outer membrane of a traumatic chronic subdural hematoma after burr-hole drainage: a case report and literature review

  2025cites this paper
• Impact of Shape Irregularity in Medial Sphenoid Wing Meningiomas on Postoperative Cranial Nerve Functioning, Proliferation, and Progression-Free Survival

  2023cites this paper
• Increased MIB-1 Labeling Index Is Associated with Abducens Nerve Morbidity in Primary Sporadic Petroclival Meningioma Surgery: Beyond Location and Approach

  2022cites this paper
• Omega-3 effectiveness against viability extended random skin flap in rats

  2022cites this paper
• Low-Dose Acetylsalicylic Acid Treatment in Non-Skull-Base Meningiomas: Impact on Tumor Proliferation and Seizure Burden

  2022cites this paper
• Immunohistochemical Expression of MUC4 in Different Meningioma Subtypes in Comparison to Some Mesenchymal Non-Meningothelial Tumors

  2021cites this paper
• Relationship between CD 163 Tumor-Associated Macrophages and Colorectal-Cancer Stem Cell Markers

  2021cites this paper
• 10 Management of Benign Skull Base Tumors in Neuro-oncology: Systemic Cytotoxic and Targeted Therapies Systemic cytotoxic and targeted therapies Benign skull base tumors in neuro-oncology

  2021cites this paper
• The role of systemic inflammatory cells in meningiomas

  2021cites this paper
• Cannabinoids for Neurological Conditions

  2021cites this paper
• Association between CD133 expression and clinicopathological profile in colorectal cancer.

  2020cites this paper
• Recurrence/Regrowth in Grade I Meningioma: How to Predict?

  2020cites this paper
• Identification of a Transcription Factor-microRNA-Gene Coregulation Network in Meningioma through a Bioinformatic Analysis

  2020cites this paper
• The Relationship between Glucose Transporter 1 (GLUT1) Expression and the Clinicopathology of Patients with Adenocarcinoma and Squamous Cell Carcinoma Lung Cancer at H. Adam Malik General Hospital Medan

  2020cites this paper
• ASSOCIATION OF E-CADHERIN EXPRESSION TO CLINICAL STAGE OF NASOPHARYNGEAL CARCINOMA

  2019cites this paper
• Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers

  2019cites this paper
• Canine brain tumours: a model for the human disease?

  2017cites this paper
• Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma.

  2016cites this paper
• Systemic therapy for recurrent meningioma

  2016cites this paper
• Genetic/molecular alterations of meningiomas and the signaling pathways targeted

  2015cites this paper
• Patterns of protein expression and cytogenetic alterations in meningiomas: relationship with the clinical and biological features of the disease

  2015cites this paper
• Poly(ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas.

  2014cites this paper
• Hubungan Imunoekspresi Human Telomerase Reserve Transcriptase (hTERT) dan Vascular Endothelial Growth Factor (VEGF) dengan Gradasi Histopatologi Meningioma

  2014cites this paper
• Association between nonsteroidal anti‐inflammatory drug use and brain tumour risk: a meta‐analysis

  2014cites this paper
• An observational study on the expression of cyclooxygenase-2 in meningioma

  2014cites this paper
• Immunohistochemical analysis of cyclooxygenase‐2 and brain fatty acid binding protein expression in grades I‐II meningiomas: Correlation with tumor grade and clinical outcome after radiotherapy

  2014cites this paper
• Non-steroidal anti-inflammatory drug use and brain tumour risk: a case–control study within the Clinical Practice Research Datalink

  2013cites this paper